Heartflow Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Heartflow Inc.
- Former names
- Cardiovascular Simulation, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Francisco
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- HTFL
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001464521
- EIN
- 26-0506743
Board of directors
-
Casey M. Tansey · DirectorSince 2025
-
Jeffrey C. Lightcap · DirectorSince 2025
-
John C.m. Farquhar · Director · Chief Executive OfficerSince 2025
-
Julie A. Cullivan · DirectorSince 2025
-
Nicholas Downing · DirectorSince 2025
-
Timothy C. Barabe · DirectorSince 2025
-
Wayne Joseph Riley · DirectorSince 2025
-
William C. Weldon · DirectorSince 2025
Chief executives
John C.m. Farquhar
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of June 16, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
89.6%
-
90.1%
Board connections
5 of this board's directors also sit on 8 other boards.
- via Julie A. Cullivan
- via Wayne Joseph Riley
- via Timothy C. Barabe
- via Wayne Joseph Riley
- via Casey M. Tansey
- via Casey M. Tansey
- via Nicholas Downing
- via Casey M. Tansey
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,053,600
- 1 purchase by 1 insider
- Sold, last 12 months
- $138,076,448
- 36 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 18, 2026 | Rogers Campbell Officer (Chief Medical Officer) | Option exercise | +12,329 | $8.33 | $102,701 |
| Sep 18, 2026 | Verghese Vikram Officer (Chief Financial Officer) | Open-market sale | −16,766 | $50.75 | $850,926 |
| Sep 18, 2026 | Rogers Campbell Officer (Chief Medical Officer) | Option exercise | +850 | $2.22 | $1,887 |
| Sep 18, 2026 | Rogers Campbell Officer (Chief Medical Officer) | Open-market sale | −19,682 | $50.15 | $987,052 |
| Sep 17, 2026 | Verghese Vikram Officer (Chief Financial Officer) | Open-market sale | −7,579 | $50.11 | $379,816 |
| Sep 15, 2026 | Verghese Vikram Officer (Chief Financial Officer) | Open-market sale | −668 | $50.01 | $33,408 |
| Sep 14, 2026 | Verghese Vikram Officer (Chief Financial Officer) | Open-market sale | −4,593 | $50.24 | $230,744 |
| Sep 11, 2026 | Verghese Vikram Officer (Chief Financial Officer) | Open-market sale | −29,714 | $50.06 | $1,487,459 |
| Sep 11, 2026 | John C.m. Farquhar Director, Officer (Chief Executive Officer) | Open-market sale | −3,890 | $50.00 | $194,500 |
| Sep 10, 2026 | John C.m. Farquhar Director, Officer (Chief Executive Officer) | Open-market sale | −35,010 | $46.42 | $1,625,105 |
| Sep 8, 2026 | Verghese Vikram Officer (Chief Financial Officer) | Open-market sale | −6,640 | $50.03 | $332,212 |
| Sep 3, 2026 | Verghese Vikram Officer (Chief Financial Officer) | Open-market sale | −27,540 | $49.69 | $1,368,471 |
| Sep 2, 2026 | Verghese Vikram Officer (Chief Financial Officer) | Open-market sale | −5,876 | $50.60 | $297,326 |
| Aug 21, 2026 | John C.m. Farquhar Director, Officer (Chief Executive Officer) | Open-market sale | −27,230 | $50.00 | $1,361,500 |
| Aug 18, 2026 | John C.m. Farquhar Director, Officer (Chief Executive Officer) | Open-market sale | −32,676 | $45.00 | $1,470,420 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.